PMV Pharmaceuticals, Inc. (PMVP) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 95.78M | 115.23M | 132.45M | 145.31M | 163.5M | 175.66M | 189.62M | 218.79M | 202.46M | 207.41M | 205.3M | 190.41M |
| Cash & Short-Term Investments | 93.55M | 112.94M | 129.25M | 142.27M | 160.39M | 169.45M | 182.84M | 212.92M | 197.94M | 203.06M | 201.92M | 187.09M |
| Cash Only | 39.13M | 37.98M | 36.34M | 44.13M | 51.34M | 40.88M | 48.81M | 48.53M | 47.65M | 37.71M | 52.06M | 68.21M |
| Short-Term Investments | 54.42M | 74.96M | 92.91M | 98.15M | 109.05M | 128.58M | 134.03M | 164.39M | 150.28M | 165.35M | 149.86M | 118.88M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 2.23M | 2.28M | 3.2M | 3.04M | 3.11M | 6.2M | 6.78M | 822K | 822K | 4.35M | 3.38M | 822K |
| Total Non-Current Assets | 782K | 1.33M | 1.4M | 7.54M | 7.11M | 15.63M | 33.88M | 18.75M | 34.42M | 44.74M | 55.73M | 51.8M |
| Property, Plant & Equipment | 486K | 1.04M | 1.15M | 1.26M | 1.44M | 1.55M | 18.54M | 18.57M | 19.11M | 19.05M | 19.37M | 19.86M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 6.03M | 5.43M | 13.84M | 15.1M | 0 | 15.12M | 25.5M | 36.18M | 31.76M |
| Other Non-Current Assets | 296K | 297K | 249K | 248K | 237K | 235K | 242K | 182K | 182K | 190K | 180K | 181K |
| Total Assets | 96.56M | 116.56M | 133.84M | 152.85M | 170.61M | 191.29M | 223.5M | 237.54M | 236.88M | 252.15M | 261.03M | 242.22M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -43.4% | -39.06% | -40.11% | -35.65% | -27.98% | -24.14% | -14.38% | -1.93% | -6.73% | -6.72% | -8.41% | -19.41% |
| Total Current Liabilities | 8.6M | 11.41M | 12.3M | 11.61M | 9.76M | 14.37M | 13.56M | 11.38M | 12.06M | 14.03M | 10.72M | 11.45M |
| Accounts Payable | 1.63M | 3.15M | 3.4M | 2.6M | 3.59M | 6.58M | 2.06M | 4.53M | 859K | 3.24M | 1.68M | 3.49M |
| Days Payables Outstanding | 6.33K | - | - | 8.8K | - | - | - | 659.51 | 514.83 | 629.78 | - | - |
| Short-Term Debt | 293K | 403K | 0 | 0 | 0 | 352K | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 6.67M | 7.86M | 3.92M | 3.06M | 2.78M | 5M | 10.26M | 0 | 0 | 4.5M | 0 | 0 |
| Current Ratio | 11.14x | 10.09x | 10.76x | 12.52x | 16.75x | 12.22x | 13.98x | 19.22x | 16.79x | 14.78x | 19.16x | 16.63x |
| Quick Ratio | 11.14x | 10.09x | 10.76x | 12.52x | 16.75x | 12.22x | 13.98x | 19.22x | 16.79x | 14.78x | 19.16x | 16.63x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 435K | 541K | 643K | 742K | 838K | 12.02M | 11.84M | 12.14M | 12.43M | 12.7M | 12.96M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 435K | 541K | 643K | 742K | 838K | 12.02M | 11.84M | 12.14M | 12.43M | 12.7M | 12.96M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 8.6M | 11.85M | 12.85M | 12.25M | 10.5M | 15.21M | 25.59M | 23.22M | 24.2M | 26.46M | 23.41M | 24.41M |
| Total Debt | 293K | 838K | 931K | 1.02M | 1.11M | 1.19M | 13.27M | 12.99M | 13.02M | 13.29M | 12.7M | 12.98M |
| Net Debt | -38.84M | -37.15M | -35.41M | -43.11M | -50.23M | -39.69M | -35.54M | -35.54M | -34.63M | -24.42M | -39.36M | -55.23M |
| Debt / Equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.07x | 0.06x | 0.06x | 0.06x | 0.05x | 0.06x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 87.97M | 104.71M | 121M | 140.6M | 160.11M | 176.08M | 197.91M | 214.31M | 212.68M | 225.69M | 237.61M | 217.81M |
| Equity Growth % | -45.06% | -40.53% | -38.86% | -34.39% | -24.72% | -21.98% | -16.71% | -1.6% | -7.6% | -8.27% | -9.03% | -21.36% |
| Book Value per Share | 1.65 | 1.97 | 2.28 | 2.70 | 3.08 | 3.41 | 3.84 | 4.16 | 4.13 | 4.39 | 4.84 | 4.75 |
| Total Shareholders' Equity | 87.97M | 104.71M | 121M | 140.6M | 160.11M | 176.08M | 197.91M | 214.31M | 212.68M | 225.69M | 237.61M | 217.81M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -464.49M | -446.45M | -428.42M | -407.36M | -386.15M | -368.71M | -345.71M | -326.49M | -325.27M | -310M | -294.25M | -277.61M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -15K | 84K | 91K | 21K | 84K | 139K | 410K | -185K | -129K | 224K | -355K | -328K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |